Study Title
A Randomised, Multi-centre, Intra-patient Imaging and Dosimetry Crossover Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Study Details
Description:
A randomised, multi-centre, intra-patient imaging and dosimetry crossover study of lutetium (177Lu) rhPSMA 10.1 and lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) in patients with non-curative metastatic prostate cancer
Sponsor:
Blue Earth Therapeutics, LTDContacts:
Blue Earth Therapeuticscontact@blueearthtx.com
+44 (0)1865634500
Government Study Link:
NCT06516510 - Click here to see study onClinicalTrials.gov
Patient Education
Patient Education Not Yet Provided
Publications
Publications Not Yet Provided
Locations
Not yet provided. Contact Blue Earth Therapeutics for more information.
+44 (0)1865634500
contact@blueearthtx.com
